NCT00006496

Brief Summary

To examine the possible relationship between genetic factors and the acute respiratory distress syndrome (ARDS).

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
4,000

participants targeted

Target at P75+ for all trials

Timeline
7mo left

Started Feb 2000

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress98%
Feb 2000Dec 2026

Study Start

First participant enrolled

February 1, 2000

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

November 16, 2000

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 17, 2000

Completed
25.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2026

Expected
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

November 29, 2024

Status Verified

November 1, 2024

Enrollment Period

26.5 years

First QC Date

November 16, 2000

Last Update Submit

November 26, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Risk of ARDS

    From admission to ICU

Secondary Outcomes (1)

  • Mortality

    From admission to ICU to 60 days

Other Outcomes (1)

  • Multi-organ Failure

    From admission to ICU

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients admitted to ICU with risk factors for ARDS

Eligibility Criteria: All those with risk factors for ARDS - eg, pneumonia, trauma, sepsis. Vulnerable populations (incarcerated, pregnant, etc.) will be excluded from enrollment. The following medical conditions will also exclude from study: 1. immunocompromised patients 2. patients with chronic lung disease that may appear like ARDS 3. pulmonary vasculitis patients 4. patients with diffuse alveolar hemorrhage 5. patients treated with immune-modulating agents within 3 weeks of admission 6. patients unable to intubate because of DNI order or patient is placed on comfort measures only

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Study Sites (1)

Massachusetts General Hospital

Boston, Massachusetts, 02114, United States

Location

Related Publications (2)

  • Gong MN, Wei Z, Xu LL, Miller DP, Thompson BT, Christiani DC. Polymorphism in the surfactant protein-B gene, gender, and the risk of direct pulmonary injury and ARDS. Chest. 2004 Jan;125(1):203-11. doi: 10.1378/chest.125.1.203.

    PMID: 14718442BACKGROUND
  • Gong MN, Thompson BT, Williams P, Pothier L, Boyce PD, Christiani DC. Clinical predictors of and mortality in acute respiratory distress syndrome: potential role of red cell transfusion. Crit Care Med. 2005 Jun;33(6):1191-8. doi: 10.1097/01.ccm.0000165566.82925.14.

    PMID: 15942330BACKGROUND

Biospecimen

Retention: SAMPLES WITH DNA

Blood will be collected for DNA extraction and plasma cytokine measurements

MeSH Terms

Conditions

Respiratory Distress SyndromeLung Diseases

Condition Hierarchy (Ancestors)

Respiratory Tract DiseasesRespiration Disorders

Study Officials

  • David Christiani, MD

    Harvard University School of Public Health

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Medicine

Study Record Dates

First Submitted

November 16, 2000

First Posted

November 17, 2000

Study Start

February 1, 2000

Primary Completion (Estimated)

August 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

November 29, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

Locations